Price Alert

BriaCell Therapeutics Cor... (BCTX)

NASDAQ: BCTX · Real-Time Price · USD

13.08

0.25 (1.95%)

At close: Oct 03, 2025, 3:59 PM

13.10

0.14%

After-hours: Oct 03, 2025, 07:54 PM EDT

BriaCell Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is August - July.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Net Income	-4.93M	-20.3M	-26.84M	-428.33K
Depreciation & Amortization	83.9K	15.27K	15.27K	15.26K
Stock-Based Compensation	1.8M	2.19M	3.07M	1.97M
Other Working Capital	1.74M	-4.19M	-640.46K	-876.45K
Other Non-Cash Items	-28.14M	-2.12M	11.66M	1.84M
Deferred Income Tax	n/a	n/a	n/a	-8.86M
Change in Working Capital	7.05M	-3.53M	-391.29K	-2.28M
Operating Cash Flow	-24.13M	-23.74M	-12.48M	-7.75M
Capital Expenditures	-456.8K	n/a	n/a	n/a
Cash Acquisitions	-225K	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	-681.8K	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	-330.4K
Common Stock Repurchased	n/a	-47.29K	-13.03M	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	1.59K	6.43M	13.7M
Financial Cash Flow	4.42M	3.95M	-3.74M	65M
Net Cash Flow	-20.39M	-19.79M	-16.23M	57.25M
Free Cash Flow	-24.58M	-23.74M	-12.48M	-7.75M